Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems
Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems Read More »
26 – 28 June 2025 | Visit us at booth #19 for a live demonstration of the latest developments across our HALO clinical and life science products on June 26-28 or prebook a meeting at our booth.
Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.
Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.
Indica Labs’ Boston HALO® User Group Meeting Read More »
In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.
Open Pathology and AI Integrations: Empowering Labs with Choice Read More »
27 March 2025 | Learn about the latest advancements in AI-powered pathology. In this webinar, we’ll introduce CRC Macrodissect AI, an advanced solution designed to assist in colorectal cancer tumor content scoring and selecting regions for downstream macrodissection.
CRC Macrodissect AI and Breast HER2 AI Sneak Peek Read More »
Albuquerque, NM and Grapevine, TX, February 4, 2025 – Indica Labs, the global leader of AI-powered digital pathology and Versant Diagnostics, an independent physician services company and proponent of next-generation digital pathology, announce today that Versant Diagnostics has chosen the HALO AP® platform from Indica Labs to further support their mission of helping world leading pathologists transition from conventional pathology to cutting edge digital technology.
Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Albuquerque, NM, 19 December 2024 -Indica Labs announced today that Molecular Pathology Laboratory Network, Inc. (MPLN), a leader in laboratory medicine, hematopathology, and solid tumor oncology testing, has selected the HALO AP® platform from Indica Labs to deliver digital pathology services to both clinical reference labs and biopharma clients.
